Grimes & Company »

Mersana Therapeutics shares owned by Grimes & Company

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Grimes & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $69k 15k 4.48
2023-12-31 $36k 16k 2.32
2023-09-30 $21k 16k 1.27
2023-06-30 $52k 16k 3.29
2023-03-31 $64k 16k 4.11
2022-12-31 $90k 15k 5.86
2022-09-30 $103k 15k 6.79
2022-06-30 $69k 15k 4.62
2022-03-31 $57k 14k 3.97